EUVIMEDEUVIMED entdecken
Crossref

The Rate of Influenza and Respiratory Syncytial Virus in Patients with Upper Respiratory Infection Symptoms During the COVID-19 Pandemic Period

Mahmut Altaş, Özlem Tataroğlu, İsmail Tayfur, Avni Uygar Seyhan, Erdal Yılmaz, Rohat Ak, Nihat Müjdat Hökenek, Elif Karagöz

Global Emergency and Critical Care · 2022

DOI: 10.4274/globecc.galenos.2022.21931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Emergency and Critical Care, 2022. Verfasst von Mahmut Altaş und 7 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study investigates the rates of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) influenza and respiratory syncytial virus (RSV) in patients who presented to the emergency department with symptoms of upper and lower respiratory tract infections during the coronavirus disease-2019 (COVID-19) pandemic. Materials and Methods:This study was conducted on patients admitted to the University of Health Sciences Turkey, Kartal Dr. Lutfi Kirdar City Hospital, Clinic of Emergency with symptoms of upper respiratory tract infection between 15.03.2021 and 15.05.2021.SARS-CoV-2 and RSV were studied using multiplex polymerase chain reaction (PCR) test on nasopharyngeal swab samples taken from these patients.The research was conducted as a prospective, descriptive case study.Patient selection was determined by physicians working in green area polyclinics.The samples are taken in the "COVID-19 PCR sample collection area of our hospital".Two nasopharyngeal swabs were taken from all patients.

Results

A total of 359 patients participated in this study.Of these patients, 51% were men and 49% were women.The age range of these patients ranged from 17 to 70, with a mean age of 36.2.Three hundred forty nine of these patients followed up as outpatients.Of the patients,71.3%included in our study had no history of comorbid disease.SARS-CoV-2 was positive in 94 of the patients participating in our study.Cough, shortness of breath, wheezing and fever were found to be significantly higher in SARS-CoV-2 patients, however nasal discharge was significantly higher in the group with patients had not SARS-CoV-2.

Conclusion

Measures taken against the transmission of SARS-CoV-2 during the pandemic period also reduced the incidence of other respiratory viruses.Historical declines have been found in the influenza and RSV ranks.When the restrictions are lifted, epidemics from other respiratory viruses are also expected.Surveillance studies of these viruses should be closely followed and should be prepared for new outbreaks.

Zitieren

APA

Altaş, M., Tataroğlu, Ö., Tayfur, İ., Seyhan, A. U., Yılmaz, E., Ak, R., Hökenek, N. M., & Karagöz, E. (2022). The Rate of Influenza and Respiratory Syncytial Virus in Patients with Upper Respiratory Infection Symptoms During the COVID-19 Pandemic Period. Global Emergency and Critical Care. https://doi.org/10.4274/globecc.galenos.2022.21931

Vancouver

Altaş M, Tataroğlu Ö, Tayfur İ, Seyhan AU, Yılmaz E, Ak R, et al. The Rate of Influenza and Respiratory Syncytial Virus in Patients with Upper Respiratory Infection Symptoms During the COVID-19 Pandemic Period. Global Emergency and Critical Care. 2022. doi:10.4274/globecc.galenos.2022.21931

BibTeX
@article{Alta2022,
  author = {Altaş, Mahmut and Tataroğlu, Özlem and Tayfur, İsmail and Seyhan, Avni Uygar and Yılmaz, Erdal and Ak, Rohat and Hökenek, Nihat Müjdat and Karagöz, Elif},
  title = {The Rate of Influenza and Respiratory Syncytial Virus in Patients with Upper Respiratory Infection Symptoms During the COVID-19 Pandemic Period},
  journal = {Global Emergency and Critical Care},
  year = {2022},
  doi = {10.4274/globecc.galenos.2022.21931}
}
Kostenlos starten →